PARP Inhibitors in Breast Cancer: a Short Communication

被引：0
作者：
Gordon R. Daly
Maen Monketh AlRawashdeh
Jason McGrath
Gavin P. Dowling
Luke Cox
Sindhuja Naidoo
Damir Vareslija
Arnold D. K Hill
Leonie Young
机构：
[1] Royal College of Surgeons in Ireland,The Department of Surgery
[2] Beaumont Hospital,The Department of Surgery
来源：
Current Oncology Reports | 2024年 / 26卷
关键词：
PARP inhibitor; Breast cancer; BRCA; Homologous repair deficiency;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：103 / 113
页数：10
相关论文
共 50 条
  • [31] PARP inhibitors in metastatic prostate cancer
    Taylor, Amy K.
    Kosoff, David
    Emamekhoo, Hamid
    Lang, Joshua M.
    Kyriakopoulos, Christos E.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [32] PARP Inhibitors for the Treatment of Ovarian Cancer
    Cortesi, Laura
    Toss, Angela
    Cucinotto, Iole
    CURRENT CANCER DRUG TARGETS, 2018, 18 (09) : 877 - 893
  • [33] Role of PARP Inhibitors: A New Hope for Breast Cancer Therapy
    De, Kamalendu
    Jana, Malabendu
    Chowdhury, Bhabadeb
    Calaf, Gloria M.
    Roy, Debasish
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [34] PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival
    Shao, Fengping
    Duan, Yaoyun
    Zhao, Yunhe
    Li, Yinguang
    Liu, Jun
    Zhang, Cai
    He, Shanyang
    AGING-US, 2021, 13 (06): : 8975 - 8988
  • [35] PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
    Zhu, Heng
    Wei, Miaoyan
    Xu, Jin
    Hua, Jie
    Liang, Chen
    Meng, Qingcai
    Zhang, Yiyin
    Liu, Jiang
    Zhang, Bo
    Yu, Xianjun
    Shi, Si
    MOLECULAR CANCER, 2020, 19 (01)
  • [36] The current status of PARP inhibitors in ovarian cancer
    McLachlan, Jennifer
    George, Angela
    Banerjee, Susana
    TUMORI JOURNAL, 2016, 102 (05): : 433 - 440
  • [37] PARP inhibitors - current status and the walk towards early breast cancer
    Glendenning, Jennifer
    Tutt, Andrew
    BREAST, 2011, 20 : S12 - S19
  • [38] Study of PARP inhibitors for breast cancer based on enhanced multiple kernel function SVR with PSO
    Xue, Haohan
    Zhang, Ruixuan
    Yan, Xudong
    Wang, Ruihan
    Zhang, Peijian
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [39] PARP inhibitors in ovarian cancer
    Goldlust, Ian S.
    Guidice, Elena
    Lee, Jung-min
    SEMINARS IN ONCOLOGY, 2024, 51 (1-2) : 45 - 57
  • [40] PARP Inhibitors in Pancreatic Cancer
    Brown, Timothy J.
    Reiss, Kim A.
    CANCER JOURNAL, 2021, 27 (06) : 465 - 475
12345